MapLight Therapeutics faces significant setbacks after underwhelming Phase 2 ZEPHYR results for ML-007C-MA in schizophrenia.

Under a new German law, statutory health insurance funds will no longer be able to reimburse homeopathy and anthroposophic ...

Katia Beauchamp, the co-founder of Birchbox, knew it was time for the nail category to change, so she launched Buff Beauty, ...

An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding ...

Heyyy, it’s a brand new week, and this is the Health Brief newsletter. The House has left for August recess, but the Senate ...

A new vaccine by Pfizer and Valneva is progressing through clinical trials with a promising outlook to prevent Lyme disease.

The biggest forward question facing the Toronto Maple Leafs right now isn’t just who can play right wing next to Auston ...

To recognize the country’s 250th year, CNBC Make It got notable voices in politics, finance and relationships across age ranges to sit down and spark conversation about what it means to achieve ...

An analysis of cancer medicines approved in the past couple decades to treat adults with solid tumors revealed what ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...

The most successful deterrent threats leave no evidence behind. No missiles fly. No networks go down. No troops cross borders ...

A new court filing in the Justice Department’s case against James Comey reveals how Trump is using federal law enforcement to ...